Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sudipta Bhowmick

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Plos One|June 9, 2009
Identification of novel Leishmania donovani antigens that help define correlates of vaccine-mediated protection in visceral leishmaniasisSudipta Bhowmick, Nahid Ali
Expert Opinion on Drug Delivery|July 2, 2008
Recent developments in leishmaniasis vaccine delivery systemsSudipta Bhowmick, Nahid Ali
Vaccine|July 28, 2007
Leishmanial antigens in liposomes promote protective immunity and provide immunotherapy against visceral leishmaniasis via polarized Th1 responseSudipta Bhowmick, Rajesh Ravindran, Nahid Ali
Infection and Immunity|January 27, 2009
Vaccination route that induces transforming growth factor beta production fails to elicit protective immunity against Leishmania donovani infectionSudipta Bhowmick, Tuhina Mazumdar, Nahid Ali
BMC Microbiology|January 17, 2014
IL-4 contributes to failure, and colludes with IL-10 to exacerbate Leishmania donovani infection following administration of a subcutaneous leishmanial antigen vaccineSudipta Bhowmick, Rajesh Ravindran, Nahid Ali
BMC Microbiology|June 26, 2010
Comparison of BCG, MPL and cationic liposome adjuvant systems in leishmanial antigen vaccine formulations against murine visceral leishmaniasisRajesh Ravindran, Sudipta Bhowmick, Amrita Das, et al.
Microbiology Spectrum|August 19, 2025
Evaluation of <i>Leishmania</i> homolog of activated C kinase (LACK) of <i>Leishmania donovani</i> in comparison to glycoprotein 63 as a vaccine candidate against visceral leishmaniasisNicky Didwania, Sudipta Bhowmick, Abdus Sabur, et al.
The Indian Journal of Medical Research|June 17, 2006
Immune responses in kala-azarSamiran Saha, Smriti Mondal, Antara Banerjee, et al.
Frontiers in Immunology|February 15, 2018
Liposomal Elongation Factor-1α Triggers Effector CD4 and CD8 T Cells for Induction of Long-Lasting Protective Immunity against Visceral LeishmaniasisAbdus Sabur, Sudipta Bhowmick, Rudra Chhajer, et al.
Parasites & Vectors|June 1, 2020
Investigation of the antigenicity and protective efficacy of Leishmania promastigote membrane antigens in search of potential diagnostic and vaccine candidates against visceral leishmaniasisSarfaraz Ahmad Ejazi, Smriti Ghosh, Anirban Bhattacharyya, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Plos One|June 9, 2009
Identification of novel Leishmania donovani antigens that help define correlates of vaccine-mediated protection in visceral leishmaniasisSudipta Bhowmick, Nahid Ali
Expert Opinion on Drug Delivery|July 2, 2008
Recent developments in leishmaniasis vaccine delivery systemsSudipta Bhowmick, Nahid Ali
Vaccine|July 28, 2007
Leishmanial antigens in liposomes promote protective immunity and provide immunotherapy against visceral leishmaniasis via polarized Th1 responseSudipta Bhowmick, Rajesh Ravindran, Nahid Ali
Infection and Immunity|January 27, 2009
Vaccination route that induces transforming growth factor beta production fails to elicit protective immunity against Leishmania donovani infectionSudipta Bhowmick, Tuhina Mazumdar, Nahid Ali
BMC Microbiology|January 17, 2014
IL-4 contributes to failure, and colludes with IL-10 to exacerbate Leishmania donovani infection following administration of a subcutaneous leishmanial antigen vaccineSudipta Bhowmick, Rajesh Ravindran, Nahid Ali
BMC Microbiology|June 26, 2010
Comparison of BCG, MPL and cationic liposome adjuvant systems in leishmanial antigen vaccine formulations against murine visceral leishmaniasisRajesh Ravindran, Sudipta Bhowmick, Amrita Das, et al.
Microbiology Spectrum|August 19, 2025
Evaluation of <i>Leishmania</i> homolog of activated C kinase (LACK) of <i>Leishmania donovani</i> in comparison to glycoprotein 63 as a vaccine candidate against visceral leishmaniasisNicky Didwania, Sudipta Bhowmick, Abdus Sabur, et al.
The Indian Journal of Medical Research|June 17, 2006
Immune responses in kala-azarSamiran Saha, Smriti Mondal, Antara Banerjee, et al.
Frontiers in Immunology|February 15, 2018
Liposomal Elongation Factor-1α Triggers Effector CD4 and CD8 T Cells for Induction of Long-Lasting Protective Immunity against Visceral LeishmaniasisAbdus Sabur, Sudipta Bhowmick, Rudra Chhajer, et al.
Parasites & Vectors|June 1, 2020
Investigation of the antigenicity and protective efficacy of Leishmania promastigote membrane antigens in search of potential diagnostic and vaccine candidates against visceral leishmaniasisSarfaraz Ahmad Ejazi, Smriti Ghosh, Anirban Bhattacharyya, et al.
Pageof 1